Reishi, a Nootropic, and Adrafinil, a Stimulants, Nootropic, Eugeroics, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Reishi is classified as a Nootropic while Adrafinil is a Stimulants, Nootropic, Eugeroics, meaning they approach altered states through different pharmacological mechanisms. They share 0 documented effects in common, with 7 effects unique to Reishi and 3 unique to Adrafinil. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Level | Reishi | Adrafinil |
|---|---|---|
| Threshold | 500 mg | 100 mg |
| Light | 500–1000 mg | 150–250 mg |
| Common | 1000–3000 mg | 250–400 mg |
| Strong | 3000–5400 mg | 400–600 mg |
| Heavy | 9000 mg | 600 mg |
Reishi
Adrafinil
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.